C1 66 (Lamivudine 150 mg)

Pill with imprint C1 66 is White, Capsule-shape and has been identified as Lamivudine 150 mg. It is supplied by Cipla USA Inc.

Lamivudine is used in the treatment of hiv infection; hepatitis b; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C1 66

Lamivudine

Imprint: C1 66
Strength: 150 mg
Color: White
Size: 12.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: Cipla USA Inc.
National Drug Code (NDC): 69097-0166
Inactive Ingredients: hypromellose 2910 (15 mPa.s), magnesium stearate, microcrystalline cellulose, sodium starch glycolate type B potato, polyethylene glycol 6000, corn starch, titanium dioxide
Note: Inactive ingredients may vary.